Gene therapy breakthrough seen in Leber's congenital amaurosis

April 15, 2002

Article

Philadelphia-Much progress has been made in the development of gene therapies for retinal dystrophies during the last decade. Albert Maguire, MD

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Subscribe Now!

Recent Videos

Tia DiTommaso, PhD, the senior director of preclinical pharmacology Arbor Biotechnologies, and John Murphy, PhD, the chief scientific officer of Arbor Biotechnologies

Annaiz Grimm, BS, a research scientist at Seattle Children's Research Institute.

Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine.

About Us

Editorial

Terms and Conditions

Do Not Sell My Information

Privacy

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Gene therapy breakthrough seen in Leber's congenital amaurosis

Newsletter